rdf:type |
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0012133,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0035668,
umls-concept:C0038952,
umls-concept:C0681890,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
2
|
pubmed:dateCreated |
1995-5-23
|
pubmed:abstractText |
To evaluate whether early changes in viraemia in response to didanosine (ddI) predict death and occurrence of new AIDS-defining events.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-9370
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
|
pubmed:year |
1995
|
pubmed:articleTitle |
Response of HIV RNA to didanosine as a predictive marker of survival.
|
pubmed:affiliation |
Central Laboratory of Virology, Geneva University Hospital, Switzerland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|